The nature of the clinical presentation of HIV infection continues to evolve over time. New
cutaneous (eg, seborrheic dermatitis, onychomycosis, and tinea pedis) and systemic (eg …

Background: Mycosis fungoides-type cutaneous T-cell lymphoma is uncommon in
association with human immunodeficiency virus type 1 (HIV-1) infection. Reported patients …

Human immunodeficiency virus (HIV) infection and the acquired immunodeficiency
syndrome (AIDS) have become major health problems in the United States, and patients …

The etiology of cutaneous T-cell lymphoma (CTCL) remains unknown, with potential
infectious causes having been explored. This contribution evaluates the evidence …

Although some dermatologic diseases have decreased markedly in frequency in the potent
antiretroviral therapy era, other conditions remain common. Among patients with low CD4 …

Infection with HIV can result in many cutaneous disorders, some of which may be the
presenting sign of the disease. The cutaneous manifestations may be infectious or …

Acquired immunodeficiency syndrome was first recognized as a new disease in 1981
because of the unusual association of Kaposi's sarcoma and Pneumocystis carinii …

People living with human immunodeficiency virus (HIV) are living longer since the advent of
effective combined antiretroviral therapy (cART). While cART substantially decreases the …

Immunodeficiency alters the risk of cancer. Specific types of immune dysfunction are
associated with different tumor risks, but most tumors are related to oncogenic viruses. In …

Importance Persons with human immunodeficiency virus (HIV) have a 2.8-fold higher risk
than HIV-uninfected persons of nonmelanoma skin cancer (NMSC), defined as basal cell …